Compared to other treatment groups, immune-histochemical studies of tumor tissue samples from the group treated with aspirin and sorafenib further indicated that the expression of ACSL4 was significantly decreased while the expression of GADD45B was significantly increased (Figure 5g), thus supporting the observations made with the in vitro and mechanistic studies earlier. The gene discussed is GADD45B; the disease is neoplasm.